与库马林衍生物相关的白细胞结合性血管炎:一个案例报告
Manjappa Mahadevappa1, Himabindu Jayaprakash Narayan2, Bharath Raj Srinivasan2
1Department of Cardiology, JSS Medical College & Hospital, JSS Academy of Higher Education and Research, Mysore, Karnataka, India.
Hospital pharmacy
|December 29, 2025
概括
白细胞结晶性血管炎 (LCV) 可能是对库马林抗凝剂 (如阿切诺库马罗) 的罕见不良反应. 切换到阿皮克萨班解决了症状,表明库马林交叉反应性和需要个性化抗凝药.
科学领域:
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
- 血管医学 血管医学
背景情况:
- 库马林衍生物 (如华法林,阿库马林) 是常见的口服抗凝剂,用于预防血栓栓塞性疾病.
- 药物不良反应包括出血,皮肤亡,很少出现白细胞结合性血管炎 (LCV).
- 慢性肺炎是一种免疫媒介的小血管血管炎,通常是由药物引发的.
研究的目的:
- 报告使用阿诺库马罗二次性白细胞结晶性血管炎 (LCV) 的病例.
- 为了研究氨酸抗凝剂之间的潜在交叉反应.
- 要强调个性化抗凝策略在过敏患者的重要性.
主要方法:
- 一个53岁的女性病例报告,她有风湿性心脏病史,并进行了机械 mitra 门置换.
- 在5年阿诺库马罗治疗后,临床观察LCV的发展.
- 对改变抗凝血剂 (华法林,然后是阿皮克萨班) 的治疗反应的评估.
主要成果:
- 患者在服用阿诺库马罗时出现了LCV.
- 症状在转换为华法林后持续并恶化,表明可能的库马林交叉反应.
- 在过渡到阿皮克萨班后,LCV的完全消失发生了.
结论:
- 药物诱导的LCV是对库马林抗凝剂的显著不良反应.
- 在敏感个体中,阿诺库马罗和华法林之间的交叉反应是可能的.
- 阿皮克萨班在患有因库马林引起的过敏反应的患者中提供了安全的抗凝药替代品.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.0K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.0K
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
266
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
266
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Venous Thrombosis III: Interprofessional Care
257
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
257
Venous Thrombosis I: Introduction
267
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
267
Endocarditis II: Clinical Features of Infective Endocarditis
364
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
364


